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Abstract 
Background: Prior research suggests that substance use disorders (SUDs) are associated with risk of suicide mortal‑
ity, but most previous work has been conducted among Veterans Health Administration patients. Few studies have 
examined the relationship between SUDs and suicide mortality in general populations. Our study estimates the asso‑
ciation of SUDs with suicide mortality in a general US population of men and women who receive care across eight 
integrated health systems.
Methods: We conducted a case–control study using electronic health records and claims data from eight integrated 
health systems of the Mental Health Research Network. Participants were 2674 men and women who died by suicide 
between 2000–2013 and 267,400 matched controls. The main outcome was suicide mortality, assessed using data 
from the health systems and confirmed by state death data systems. Demographic and diagnostic data on substance 
use disorders and other health conditions were obtained from each health system. First, we compared descriptive 
statistics for cases and controls, including age, gender, income, and education. Next, we compared the rate of each 
substance use disorder category for cases and controls. Finally, we used conditional logistic regression models to 
estimate unadjusted and adjusted odds of suicide associated with each substance use disorder category.
Results: All categories of substance use disorders were associated with increased risk of suicide mortality. Adjusted 
odds ratios ranged from 2.0 (CI 1.7, 2.3) for patients with tobacco use disorder only to 11.2 (CI 8.0, 15.6) for patients 
with multiple alcohol, drug, and tobacco use disorders. Substance use disorders were associated with increased 
relative risk of suicide for both women and men across all categories, but the relative risk was more pronounced in 
women.
Conclusions: Substance use disorders are associated with significant risk of suicide mortality, especially for women, 
even after controlling for other important risk factors. Experiencing multiple substance use disorders is particularly 
risky. These findings suggest increased suicide risk screening and prevention efforts for individuals with substance use 
disorders are needed.
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Background
Suicide is a major public health concern in the United 
States; in 2014, 42,826 people died of suicide in the U.S., 
making it the country’s 10th leading cause of death [1]. 
Alcohol, tobacco, and drug use disorders have all been 
implicated in suicidal behavior in multiple studies [2–8], 
but most prior research has examined non-fatal suicidal 
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behavior such as suicide ideation or suicide attempt [2, 
4, 8].
Only a handful of studies have examined the rela-
tionship between substance use disorders (SUDs) and 
suicide mortality [2, 4, 5, 9, 10]. Of these, the majority 
have focused solely on the relationship between alcohol 
use disorder and suicide, with few studies exploring the 
potential role of other SUDs [2, 4]. Most of these stud-
ies do not consider whether multiple SUDs contribute 
greater risk than single SUDs [11]. In addition, most pre-
vious research has been limited to men, or to specific 
populations or risk groups such as veterans or psychiatric 
patients [12]. Most of these studies have also had rela-
tively small samples, making it difficult to analyze results 
by subgroup, such as gender [2, 4, 8].
A few studies have examined the relationship between 
SUDs and suicide mortality in larger samples in the U.S 
[5, 9, 10]. The results of these studies suggest several 
important considerations. First, these analyses indi-
cate that risk may differ by type of SUD, such as alcohol, 
tobacco, or other drugs [5, 9]. Second, they suggest that 
the strength of the association between SUDs and suicide 
may be greater for women than for men [9, 10]. Finally, 
these studies suggest that controlling for both physical 
health status and psychiatric comorbidity is important 
to understand the specific association between suicide 
mortality and SUDs [9]. However, these studies have all 
been conducted among Veterans Health Administration 
(VHA) patients, and thus their findings may not hold 
true for a broader general population. Specifically, mem-
bers of the VHA population are likely to have different 
risk factors, such as combat related health issues, that 
may moderate the impact of SUDs.
Our study examined the relationship between SUDS 
and suicide mortality in a general population drawn from 
8 large integrated health systems. Our goal was to esti-
mate the relationship between alcohol, tobacco, and drug 
use disorders and the risk of suicide mortality. We esti-
mated risk by single SUD diagnosis category (alcohol, 
tobacco, drug) and combinations of these categories. In 
addition, we examined stratified models by gender to 
examine whether the relationship between SUDs and 
suicide mortality was different for men and women. Our 
results may aid health systems in identifying people most 
at risk for suicide and in developing suicide prevention 
programs best suited to those at risk.
Methods
Design and data
We conducted a case–control study using data from 8 
large health care systems participating in the Mental 
Health Research Network (MHRN), a research collabo-
ration established in 2010 by the National Institute of 
Mental Health to improve understanding and manage-
ment of mental health conditions through a closer con-
nection between research, practice, and policy (http://
hcsrn .org/mhrn/en/).
MHRN members participating in this study were 
HealthPartners (Minnesota), Harvard Pilgrim Health 
Care (Massachusetts), Henry Ford Health System (Michi-
gan), and Kaiser Permanente health systems in Colorado, 
Georgia, Hawaii, Oregon, and Washington.
Cases included 2674 individuals who died by suicide 
between 2000 and 2013. Each health system maintains 
a research data warehouse organized according to the 
Health Care Systems Research Network Virtual Data 
Warehouse (VDW) model [13]. Data included in the 
VDW include insurance enrollment records, electronic 
health records (EHRs), insurance claims, pharmacy dis-
pensings, state mortality records, and census-derived 
neighborhood characteristics. We determined suicide 
death initially through data from the VDW at each site 
using International Classification of Diseases, 9th revi-
sion (ICD-9) codes (X60-X84 and Y87) [14, 15], and con-
firmed this using state death certificate data. We obtained 
data on mortality from each state system using Social 
Security numbers or a combination of patient names, 
birthdates, and demographic information.
All included study subjects had been enrolled in one 
of the 8 health systems for at least 10  months in the 
year prior to suicide death. Each case was matched by 
time period (year of index date) and site to a randomly 
selected sample of 100 members who were also enrolled 
in the health system for at least 10 months in the same 
year as cases, for a total of 267,400 matched individuals 
from the general population of health system members. 
The date of suicide was used as the index date for cases 
and all matched controls.
We gathered Information on diagnoses, health care 
encounters, and other demographic information from the 
VDW at each site. These data included electronic health 
records (EHRs) from the health systems and insurance 
claims data for members of each health system [16–19]. 
All data were harmonized between sites as part of partic-
ipation in the MHRN and are regularly assessed for qual-
ity and completeness. The Institutional Review Boards 
for each health system approved data use and research 
activities for this project.
Measures
Suicide
The primary outcome was suicide death during the 
observation period. Individuals who died from sui-
cide were cases. At each site, official regional mortality 
records were matched to all subjects by Social Security 
Numbers, patient names, birthdates, and demographic 
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profiles. Deaths were identified and method of suicide 
was obtained using the regional mortality records and 
state death certificate data.
Substance use disorders
Substance use disorders (SUDs) were the primary predic-
tors of interest. SUDs were identified using ICD-9 codes 
303–305. We categorized SUD diagnoses into major type 
of SUD, focusing on the most common categories. Spe-
cifically, we created categories reflecting only one type 
of SUD diagnosis (alcohol only, drug only, tobacco only), 
and categories reflecting diagnoses of multiple types of 
SUD (alcohol + drug, alcohol + tobacco, drug + tobacco, 
alcohol + drug + tobacco). All SUD diagnoses were 
identified in VDW records of clinical encounters that 
occurred in the year prior to the index date [15].
Demographics
In adjusted analyses we included all available demo-
graphic indicators. For each study subject, we included 
age and gender from the VDW at each site and geocoded 
data on neighborhood income and education. Specifi-
cally, we created indicators of poverty and levels of edu-
cation (college or higher vs. other). We were unable to 
include race or ethnicity for study subjects as these data 
were not available for all years of the study.
Other covariates
In adjusted analyses we also controlled for other factors 
that are known to be related to risk of suicide and that 
might confound the relationship between SUDs and risk 
of suicide. As psychiatric disorders are highly linked to 
suicide risk, we included an indicator of any psychiat-
ric disorder. We extracted diagnoses for defined mental 
health diagnoses (ICD-9 codes 291–302, and 306–319). 
We also included the Charlson Comorbidity Index to 
control for non-psychiatric medical comorbidity such 
as cancer or cardiovascular disease [20]. The Charlson 
Index was calculated using ICD-9 codes from clinical 
diagnoses. All diagnoses were identified during clinical 
encounters that occurred in the year prior to the index 
date [21].
Statistical analyses
First, we compared descriptive statistics for the cases 
and controls. We examined age, gender (male/female), 
income (proportion living in census blocks with ≥ 20% 
living below US poverty level), and education (propor-
tion living in census blocks where ≥ 25% are college 
graduates). Next, we compared the rate of each SUD 
category for cases and controls. Finally, we used condi-
tional logistic regression models to estimate unadjusted 
and adjusted odds of suicide associated with each SUD 
category. All models were conditional on site. We pre-
sent two sets of analyses, unadjusted results and results 
adjusting for age, gender, poverty level, education, 
physical health status (Charlson Index), and psychiatric 
comorbidity. All analyses were conducted using SAS [22]. 
Statistical significance was assessed with a threshold of 
p = 0.05.
Results
Table  1 compares cases and controls on demographic 
characteristics and SUD categories for the sample as a 
whole and separately by gender. Cases were significantly 
more likely than controls to be male (77.5% of cases were 
male vs. 47.5% of controls, p < 0.001) and to be older 
(average age of cases was 44.9 vs. 39.3 years for controls; 
p < 0.001). Cases were also more likely than controls 
to have psychiatric co-morbidities, as well as a higher 
Charlson Comorbidity Index score. We found no sig-
nificant difference between cases and controls when we 
examined poverty level. We found a significantly higher 
level of education for female cases.
All individual SUD categories were significantly asso-
ciated with suicide death. For instance, for the overall 
sample, the percent of cases diagnosed with alcohol use 
disorder only was more than 10 times greater than con-
trols (8.3% of cases vs. 0.6% of controls, p < 0.001). Rela-
tive differences were greatest for those who used multiple 
categories of alcohol, tobacco and drugs (3.6% of cases vs. 
0.1% of controls).
When we compared males and females separately we 
found that SUD was associated with suicide death for 
both genders. Male and female cases had a similar rate 
of some SUD diagnoses, for example 8.5% of male cases 
were diagnosed with an alcohol use disorder only (AUD) 
compared to 8% of female cases. However, the relative 
differences between cases and controls were different. 
For example, looking only at males, the percent of male 
cases diagnosed with AUD only was about 10 times 
greater than the percent diagnosed among male controls 
(8.5% of cases vs. 0.8% of controls, p < 0.001). In contrast, 
looking only at females, the percent of female cases diag-
nosed with AUD only was 20 times greater than the per-
cent diagnosed among female controls (8.0% of cases vs. 
0.4% of controls, p < 0.001). This pattern was consistent 
across most categories of SUD.
Table 2 reports results for conditional logistic regres-
sion for the entire sample. The first set of results pre-
sents unadjusted odds ratios; the second set presents 
results adjusted for age, gender, education, poverty 
level, physical health status, and psychiatric condi-
tions. All SUD categories were significantly associated 
with suicide in both models. Unadjusted odds of sui-
cide for different categories of SUDs ranged from 3.5 
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times increased risk for people with tobacco use disor-
der only (OR 3.5; CI 3.1, 4.0) to 30.7 times increased 
risk for people with alcohol, drug and tobacco use dis-
orders (OR 30.7; CI 23.3, 40.6). Adjustment for demo-
graphics, psychiatric conditions and Charlson Index of 
physical health comorbidity reduced the odds ratios, 
but all categories of SUD continued to be associated 
with suicide at levels that were statistically significant. 
For example, odds of suicide adjusted for age, gender, 
education, poverty level, psychiatric conditions, and 
Charlson Index ranged from 2.0 times increased risk 
for people with tobacco use disorder only (OR 2.0; CI 
1.7, 2.3) to 11.2 times for people with alcohol, drug and 
tobacco use disorders (OR 11.2; CI 8.0, 15.6). Condi-
tional logistic regression results stratified by gender are 
presented in Table  3. Comparing male cases to male 
controls, adjusted odds of suicide for different cat-
egories of SUD ranged from 1.8 times increased risk 
for males with tobacco use disorder only (OR 1.8; CI 
1.6,2.1) to 7.9 times for males with alcohol, drug and 
Table 2 Risk of suicide by substance use disorder category, whole sample
a All conditional logistic regression models are conditional on site
b CI denotes 95% confidence interval
Substance use disorder category Odds  ratioa Adjusted odds (adjusted for age, gender, 
poverty level, education, Charlson index, 
psychiatric diagnoses)
OR CIb p-value aOR CI p-value
Alcohol only 15.5 13.1, 18.4 0.001 5.8 4.7, 7.1 0.001
Drug only 11.3 8.8, 14.4 0.001 5.3 3.9, 7.0 0.001
Tobacco only 3.5 3.1, 4.0 0.001 2.0 1.7, 2.3 0.001
Alcohol + drug 21.8 16.2, 29.3 0.001 8.1 5.7, 11.5 0.001
Alcohol + tobacco 19.5 15.8, 24.2 0.001 6.1 4.8, 7.9 0.001
Drug + tobacco 14.1 10.2, 19.6 0.001 5.0 3.4, 7.4 0.001
Alcohol + drug + tobacco 30.7 23.3, 40.6 0.001 11.2 8.0, 15.6 0.001
Table 3 Risk of suicide by substance use disorder category, by gender
a All conditional logistic regression models are conditional on site
b CI denotes 95% confidence interval
Substance use disorder category Odds  ratioa Adjusted odds (adjusted for age, 
education level, poverty level, Charlson 
index, psychiatric diagnoses)
OR CIb p-value aOR CI p-value
Male only
 Alcohol only 11.7 9.6 14.3 0.001 4.6 3.7, 5.6 0.001
 Drug only 8.2 6.1, 11.2 0.001 4.0 2.9, 5.4 0.001
 Tobacco only 3.5 3.1, 4.1 0.001 1.8 1.6, 2.1 0.001
 Alcohol + drug 14.5 10.1, 20.7 0.001 6.3 4.4, 9.0 0.001
 Alcohol + tobacco 13.6 10.6, 17.5 0.001 5.5 4.2, 7.0 0.001
 Drug + tobacco 10.4 6.8, 16.1 0.001 3.5 2.3, 5.4 0.001
 Alcohol + drug + tobacco 19.5 13.9, 27.4 0.001 7.9 5.6, 11.1 0.001
Female only
 Alcohol only 22.4 14.8, 34.00 0.001 10.7 6.3, 18.1 0.001
 Drug only 13.9 8.5, 22.8 0.001 5.2 2.9, 9.1 0.001
 Tobacco only 3.8 3.0, 4.9 0.001 2.5 1.9, 3.3 0.001
 Alcohol + drug 34.3 17.3, 68.0 0.001 11.8 5.4, 25.8 0.001
 Alcohol + tobacco 23.0 13.8, 38.3 0.001 6.5 3.6. 11.8 0.001
 Drug + tobacco 32.9 17.6, 61.4 0.001 10.4 4.9, 22.0 0.001
 Alcohol + drug + tobacco 53.5 27.4, 104.3 0.001 16.7 7.9, 35.3 0.001
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tobacco use disorders (OR 7.9; CI 5.6, 11.1). Compar-
ing female cases to female controls, adjusted odds of 
suicide for different categories of SUD ranged from 2.5 
times increased risk for females with tobacco use disor-
der only (OR 2.5; CI 1.9, 3.3) to 16.7 times for females 
with alcohol, drug and tobacco use disorders (OR 16.7; 
CI 7.9, 35.3). All categories of SUD continued to be sig-
nificant after adjustments for other risk factors for both 
males and females.
Discussion
We estimated the risk of suicide associated with SUDs 
for a general population sample of men and women who 
receive care in 8 large integrated health care systems 
spanning a variety of regions across the U.S. Our results 
suggest that SUDs are associated with significantly 
increased risk of suicide even after adjusting for other 
factors that are known to increase risk of suicide, such 
as psychiatric conditions or physical health comorbid-
ity. We also examined the association of SUDs with risk 
of suicide for males and females separately. Our results 
indicate that all categories of SUD are associated with 
significantly increased risk of suicide for both males and 
females. Consistent with other studies and known epi-
demiology [1], we found that in general, men were more 
likely than women to have died from suicide. For men, the 
relative risk of suicide associated with SUDs was between 
1.8 (tobacco only) and 7.9 (alcohol + drug + tobacco). 
For women, the relative risk of suicide associated with 
SUDs was between 2.5 (tobacco only) and 16.7 (alco-
hol + drug + tobacco). Finally, we found that having mul-
tiple SUDs was associated with significantly greater risk 
of suicide mortality than any of the other SUD categories.
The most comparable study to ours is a recent analy-
sis using data from the VHA [9]. Bohnert and colleagues 
found increased risk associated with several categories of 
SUD amongst persons served at VHA facilities. Although 
the methods are not directly comparable to ours, due to 
differences in underlying study design, our results are 
generally in line with Bohnert’s findings that SUDs are 
consistently associated with an increased risk of suicide 
mortality. However, in the current study we also find that 
even after controlling for other important risk factors (e.g., 
psychiatric diagnoses), all categories of SUD are associ-
ated with increased risk of suicide. In contrast, Bohnert 
et  al. find that after adjusting for other risks, increased 
risk of suicide death is only associated with some kinds of 
SUD. In addition, Bohnert et al. did not examine diagno-
sis of multiple types of SUD, while our work suggests that 
diagnosis of multiple SUDs is associated with increased 
risk of suicide beyond that associated with any one cat-
egory of SUD.
Our results suggest that increased screening for suicide 
risk in persons identified with SUDs may be warranted. 
This might include screening for suicide risk at entry to 
substance use treatment programs, or ongoing monitor-
ing for suicide risk during treatment. Although this type 
of screening or monitoring may be currently happening 
in some health care systems, more research is needed 
on systematic programs for monitoring and mitigating 
risk of suicide in persons with SUD. The small number 
of studies reported in the literature to date suggest that 
many addiction providers may not have formal training 
in suicide risk assessment, or may not consistently incor-
porate it into care [23]. In addition, health systems might 
want to consider suicide prevention screening for per-
sons identified with SUDs in other settings such as pri-
mary care or emergency settings, where persons may be 
identified with SUD who are not currently in addiction 
treatment.
We find that all categories of SUD are associated with 
significant risk of suicide in both men and women even 
after controlling for known risk factors, such as psychi-
atric conditions, or physical health status. We also find 
that the relative risk associated with SUD is particularly 
high for women. This result is consistent with observa-
tions in the literature suggesting that women may be 
reluctant to seek care for substance use conditions com-
pared to men, such that the women who are diagnosed 
have more severe conditions [24]. Our results suggest 
that health systems pay particular attention to risk of sui-
cide in women with SUD. In addition, further research to 
explore potential differences in how SUD influences risk 
of suicide in men and women could help to shape future 
suicide screening and treatment efforts. Our results are 
consistent with, but somewhat different than, previous 
work. Similar to our findings, Bohnert et  al. [9] found 
that after controlling for demographic factors and psy-
chiatric comorbidity, the relative risk of SUD associated 
with suicide mortality was greater for women compared 
to men. However, we find a larger difference in relative 
risk of suicide for women compared with men associ-
ated with SUD. Bohnert et al. [9] included only patients 
served through VHA, and this limits the generalizability 
of results to a broader population. Our study includes a 
greater number of women who died of suicide than Boh-
nert et al. (602 in current study compared to 291 in the 
VHA study); thus, our study has more power to look at 
women separately from men.
Many persons with SUD have multiple diagnoses 
across different categories of SUD (e.g., alcohol, drugs) 
[25], yet few studies have examined the difference in risk 
of suicide mortality for single compared to multiple SUD 
diagnoses. We know of only one study from Mexico that 
has reported on this issue [26]. Consistent with Ocampo 
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and colleagues, we found that diagnoses of multiple types 
of SUD are associated with greatly increased risk of sui-
cide mortality for both men and women.
SUDs and some psychiatric conditions often occur 
together [27]. Yet, little previous research on risk of sui-
cide mortality has been able to control for the effect of 
SUD in the context of other health conditions such as 
psychiatric conditions or physical health disorders [2]. 
The few studies that have addressed this issue suggest 
that specific psychiatric conditions, such as depression 
or bipolar disorder, may account for a significant por-
tion of the relationship between SUD and suicide mor-
tality [9, 28]. Our findings also suggest that psychiatric 
conditions likely play an important role in suicide mor-
tality in those with SUD, but we also find that even after 
controlling for many types of psychiatric conditions, 
all categories of SUD remain important risk factors for 
suicide mortality.
Our results should be considered in light of several 
limitations. All persons included in our study were 
covered by private or public health insurance and were 
members of established integrated health systems. 
Therefore, the results may not apply to persons with-
out insurance or those served by more fragmented sys-
tems. Although the sample of cases is relatively large 
for a study of suicide death, some of the subgroup 
analyses include small numbers of subjects, resulting 
in relatively wide confidence intervals. Because this is 
an observational study, we cannot rule out confounding 
due to unmeasured factors. In particular, we were not 
able to include some demographic variables that may 
be important moderators of the relationship between 
SUDs and suicide risk such as race or ethnicity, employ-
ment status, or marital status. We included adjustment 
for known psychiatric conditions, however, it is possi-
ble that some patients with SUD may have undiagnosed 
psychiatric conditions and that could account for some 
of the increased risk of SUD that we identified. We 
were not able to examine the risk associated with some 
specific individual types of drugs (e.g., marijuana), and 
it is possible that the risks may differ by type of drug. 
We also did not have measures of the severity of SUD. 
Those with more severe disorders may be driving the 
differences in suicide risk that we observe. Information 
on diagnoses of SUD are dependent on health care pro-
viders coding these diagnoses; thus some individuals 
with SUD may have been missed because health care 
providers did not recognize the disorder, or chose not 
to record the diagnosis. Thus, some controls may have 
undiagnosed SUD and this may make our results some-
what conservative. Although we included health system 
members from multiple states representing different 
geographic regions, not all U.S. states or healthcare 
settings were represented. In contrast to previous work, 
we did not match on age and gender. We limited match-
ing to location and year, so that future analyses in this 
line of research could investigate variation in subgroups 
through analyses using interaction, stratification, and 
adjustment. In lieu of matching, this study adjusted the 
analyses for both age and gender. Although we used 
robust methods for identifying suicide death [29], it 
is possible that some deaths identified as suicide were 
accidental overdoses, as this can be difficult to distin-
guish in persons with some types of SUD [30].
Despite these limitations, our study provides one of the 
first reports of risk of suicide amongst individuals with 
SUDs in a general population. All SUD categories stud-
ied were associated with increased risk of suicide and our 
results suggest that health systems could increase screen-
ing and monitoring of suicide risk and plan services to 
help address suicide risk amongst persons with SUD. The 
focus of this study was examining the risk of suicide for 
persons with SUD. However, persons who are identified 
by health systems as at risk for suicide are also more likely 
at risk for SUD [31], therefore health systems may want 
to screen persons identified as at risk for suicide for SUD 
and to offer evidence-based treatment for SUD where 
warranted. Health systems may want to pay particular 
attention to how current services address suicide risk for 
women with SUD. Future research to better understand 
the significant relative risk of suicide amongst women 
with SUD could greatly aid health systems and providers 
to better serve women with SUD.
Conclusions
Substance use disorders are associated with significant 
risk of suicide mortality, especially for women, even after 
controlling for other important risk factors. Experienc-
ing multiple substance use disorders is particularly risky. 
These findings suggest the need for increased suicide risk 
screening and prevention efforts for individuals with sub-
stance use disorders.
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